What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Blood pressure
- Diabetes mellitus
His scientific interests lie mostly in Internal medicine, Blood pressure, Endocrinology, Sympathetic nervous system and Cardiology.
His studies in Denervation, Diastole, Renal function, Obesity and Renal sympathetic denervation are all subfields of Internal medicine research.
His work deals with themes such as Dialysis, Randomized controlled trial and Kidney surgery, which intersect with Denervation.
His studies in Blood pressure integrate themes in fields like Renal artery, Surgery and Intensive care medicine.
His Sympathetic nervous system research includes elements of Neuroscience and Weight loss.
The Cardiology study combines topics in areas such as Stroke, Ambulatory, Kidney and Kidney disease.
His most cited work include:
- Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial (1869 citations)
- Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study (1808 citations)
- Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension (750 citations)
What are the main themes of his work throughout his whole career to date?
Markus P. Schlaich spends much of his time researching Internal medicine, Blood pressure, Cardiology, Endocrinology and Denervation.
His study in the field of Sympathetic nervous system, Kidney, Renal function and Kidney disease is also linked to topics like In patient.
The study incorporates disciplines such as Disease, Baroreflex and Neuroscience in addition to Sympathetic nervous system.
His Blood pressure research is multidisciplinary, relying on both Anesthesia, Clinical trial and Intensive care medicine.
Markus P. Schlaich works mostly in the field of Cardiology, limiting it down to concerns involving Resistant hypertension and, occasionally, Ablation.
His research integrates issues of Sympathectomy, Ambulatory, Surgery, Catheter and Urology in his study of Denervation.
He most often published in these fields:
- Internal medicine (105.39%)
- Blood pressure (64.48%)
- Cardiology (58.66%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (105.39%)
- Cardiology (58.66%)
- Blood pressure (64.48%)
In recent papers he was focusing on the following fields of study:
Markus P. Schlaich focuses on Internal medicine, Cardiology, Blood pressure, Sympathetic nervous system and Denervation.
Markus P. Schlaich interconnects Endocrinology and Retinal in the investigation of issues within Internal medicine.
His Heart failure study, which is part of a larger body of work in Cardiology, is frequently linked to In patient, bridging the gap between disciplines.
His work on Rostral ventrolateral medulla as part of general Blood pressure study is frequently linked to Vascular compression, therefore connecting diverse disciplines of science.
His biological study spans a wide range of topics, including Sodium/Glucose Cotransporter 2, Disease, Pharmacology and SGLT2 Inhibitor.
The various areas that Markus P. Schlaich examines in his Denervation study include Receptor, Common hepatic artery, Kidney and Urology.
Between 2019 and 2021, his most popular works were:
- 2020 International Society of Hypertension global hypertension practice guidelines (147 citations)
- 2020 International Society of Hypertension global hypertension practice guidelines (147 citations)
- 2020 International Society of Hypertension global hypertension practice guidelines. (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Blood pressure
- Diabetes mellitus
Markus P. Schlaich mostly deals with Internal medicine, Sympathetic nervous system, Cardiology, Intensive care medicine and Denervation.
His study in Internal medicine is interdisciplinary in nature, drawing from both Diabetes mellitus, Endocrinology and Retinal.
His Sympathetic nervous system research is multidisciplinary, incorporating elements of Cardiometabolic disease, Disease, Heart failure, SGLT2 Inhibitor and Sodium/Glucose Cotransporter 2.
He combines subjects such as Creatinine, Diastole and Kidney disease with his study of Cardiology.
His Intensive care medicine study deals with MEDLINE intersecting with Medication adherence, Masked Hypertension, Resistant hypertension and Clinical trial.
His work carried out in the field of Denervation brings together such families of science as Common hepatic artery, Homeostasis, Bioinformatics, Neuromodulation and Kidney.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
